Примери за използване на Bayer will на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
medical devices- which are not in scope of the Disclosure Code-, Bayer will disclose such transfers of value in full.
Bayer will remain the company name.
Bayer will remain the company name.
Bayer will become Monsanto's sole shareholder Thursday.
Bayer will probably make a higher bid,
Bayer will appeal against the recent ruling of the General Court of the European Union in Case T-429/13.
Bayer will likely come back with a higher bid,
Bayer will not only provide financial support for promising proposals
Bayer will provide an update on the total expected synergies from the Monsanto acquisition latest upon closing of the transaction.
If this happens, Bayer will report all Transfers of Value to such Healthcare Professionals in the aggregated section of the report.
Bayer will also continue to support the World Health Organization(WHO)
Bayer will report and review its sustainability targets in the same way as it does its financial targets
If such consent was not granted, Bayer will publish the Transfers of Value only in the aggregated section of the report, without mentioning the name of the recipient.
other antitrust enforcers, Bayer will sell assets with revenues of €2.2 billion to BASF for €7.6 billion.
In fact, Bayer will soon find themselves in a position where they can cause deadly cancer,
Bayer will seek to continuously improve the EIQ of its crop solutions by investing in innovation for seeds and traits, digital farming,
Bayer will probably try to disassemble the case using scientific literature,
Following a 2016 joint venture with Versant Ventures to establish BlueRock Therapeutics, Bayer will acquire the remaining stake for approximately $240 million in cash upfront at closing,
Following a 2016 joint venture with Versant Ventures to establish BlueRock Therapeutics, Bayer will acquire the remaining stake for approximately USD 240 million in cash to be paid upfront at closing
BlueRock Therapeutics today announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology